Epigenetic Silencing of the p16INK4a Tumor Suppressor Is Associated with Loss of CTCF Binding and a Chromatin Boundary

被引:179
作者
Witcher, Michael [1 ]
Emerson, Beverly M. [1 ]
机构
[1] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA
关键词
ENHANCER-BLOCKING ACTIVITY; MAMMARY EPITHELIAL-CELLS; DNA METHYLATION; PROMOTER METHYLATION; BREAST-CANCER; PROTEIN CTCF; LUNG-CANCER; HYPERMETHYLATION; EXPRESSION; GENE;
D O I
10.1016/j.molcel.2009.04.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p16(INK4a) tumor suppressor gene is a frequent target of epigenetic inactivation in human cancers, which is an early event in breast carcinogenesis. We describe the existence of a chromatin boundary upstream of the p16 gene that is lost when this gene is aberrantly silenced. We show that the multifunctional protein CTCF associates in the vicinity of this boundary and absence of binding strongly coincides with p16 silencing in multiple types of cancer cells. CTCF binding also correlates with RASSF1A and CDH1 gene activation, and CTCF interaction is absent when these genes are methylated and silenced. Interestingly, defective poly(ADP-ribosyl)ation of CTCF and dissociation from the molecular chaperone Nucleolin occur in p 16-silenced cells, abrogating its proper function. Thus, destabilization of specific chromosomal boundaries through aberrant crosstalk between CTCF, poly(ADP-ribosyl)ation, and DNA methylation may be a general mechanism to inactivate tumor suppressor genes and initiate tumorigenesis in numerous forms of human cancers.
引用
收藏
页码:271 / 284
页数:14
相关论文
共 45 条
  • [1] Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
    Belinsky, SA
    Nikula, KJ
    Palmisano, WA
    Michels, R
    Saccomanno, G
    Gabrielson, E
    Baylin, SB
    Herman, JG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) : 11891 - 11896
  • [2] The protein CTCF is required for the enhancer blocking activity of vertebrate insulators
    Bell, AC
    West, AG
    Felsenfeld, G
    [J]. CELL, 1999, 98 (03) : 387 - 396
  • [3] DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2′-deoxycytidine
    Bovenzi, V
    Lê, NLO
    Cóté, S
    Sinnett, D
    Momparler, LF
    Momparler, RL
    [J]. ANTI-CANCER DRUGS, 1999, 10 (05) : 471 - 476
  • [4] The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells
    Bracken, Adrian P.
    Kleine-Kohlbrecher, Daniela
    Dietrich, Nikolaj
    Pasini, Diego
    Gargiulo, Gaetano
    Beekman, Chantal
    Theilgaard-Monch, Kim
    Minucci, Saverio
    Porse, Bo T.
    Marine, Jean-Christophe
    Hansen, Klaus H.
    Helin, Kristian
    [J]. GENES & DEVELOPMENT, 2007, 21 (05) : 525 - 530
  • [5] DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter
    Butcher, DT
    Mancini-DiNardo, DN
    Archer, TK
    Rodenhiser, DI
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) : 669 - 678
  • [6] Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF
    De la Rosa-Velazquez, Inti A.
    Rincon-Arano, Hector
    Benitez-Bribiesca, Luis
    Recillas-Targa, Felix
    [J]. CANCER RESEARCH, 2007, 67 (06) : 2577 - 2585
  • [7] p16INK4a promoter methylation and protein expression in breast fibroadenoma and carcinoma
    Di Vinci, A
    Perdelli, L
    Banelli, B
    Salvi, S
    Casciano, I
    Gelvi, I
    Allemanni, G
    Margallo, E
    Gatteschi, B
    Romani, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (03) : 414 - 421
  • [8] Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2′-deoxycytidine treatment
    Egger, Gerda
    Aparicio, Ana M.
    Escobar, Sonia G.
    Jones, Peter A.
    [J]. CANCER RESEARCH, 2007, 67 (01) : 346 - 353
  • [9] Fahrner JA, 2002, CANCER RES, V62, P7213
  • [10] Epigenetics at the epicenter of modern medicine
    Feinberg, Andrew P.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (11): : 1345 - 1350